IP Library › Granted Patent US 10,792,390
Granted Patent B2
US 10,792,390 · App. 16/717,965 · Granted Oct 6, 2020

Particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Steve Plotkin (Aliso Viejo, CA); Xinping Wu (Aliso Viejo, CA)
Assignee: MicroVention, Inc.
A61L24/06A61L24/001C08F222/385A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,792,390
App. No.
16/717,965
Granted
Oct 6, 2020
Kind
B2
Abstract

Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.

Claims (25)

1. An embolic composition including:

embolic particles including a reaction product of a prepolymer solution including:

a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof;

at least one monomer, and

a visualization agent,

wherein the embolic particles have a diameter between about 40 μm and about 1,500 μm.

2. The embolic composition of claim 1 , wherein the visualization agent is particles of radiopaque materials or halogen containing monomers.

3. The embolic composition of claim 2 , wherein the halogen containing monomer is an iodine containing monomer.

4. The embolic composition of claim 3 , wherein the iodine containing monomer has a structure:

5. The embolic composition of claim 2 , wherein the particles of radiopaque materials include barium, bismuth, tantalum, platinum, and gold.

6. The embolic composition of claim 2 , wherein the particles of radiopaque materials include barium sulfate.

7. The embolic composition of claim 2 , wherein the particles of radiopaque materials include bismuth.

8. The embolic composition of claim 1 , wherein the diameter is between about 400 μm and about 1,500 μm.

9. The embolic composition of claim 1 , wherein the at least one monomer includes ionic groups.

10. The embolic composition of claim 9 , wherein the monomer containing ionic groups is sodium acrylate.

11. The embolic composition of claim 1 , wherein the prepolymer solution further includes a crosslinker.

12. The embolic composition of claim 11 , wherein the crosslinker is biodegradable.

13. The embolic composition of claim 11 , wherein the crosslinker has a structure:

wherein each n is independently 1-20;

wherein d, e, and f are each independently 1-20; or

14. The embolic composition of claim 1 , wherein the macromer is a crosslinker.

15. The embolic composition of claim 1 delivered through a catheter.

16. The embolic composition of claim 15 , wherein the catheter is a microcatheter.

17. The embolic composition of claim 15 , wherein the catheter includes a flow diverting stent formed of a material having a pore size.

18. The embolic system of claim 17 , wherein the pore size is less than the diameter of the embolic particles.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2019
From: CRUISE, GREGORY M.; PLOTKIN, STEVE; WU, XINPING
To: MICROVENTION, INC.
Reel/Frame 051310/0592 →
Continuity (6)
Continuation 16505326 · Jul 8, 2019
Continuation 16184862 · Nov 8, 2018
Continuation 15878294 · Jan 23, 2018
Continuation 15081648 · Mar 25, 2016
Provisional Application 62138859 · Mar 26, 2015
Related Publication 20200121824A1 · Apr 23, 2020
Cited By (2)
US 12,364,786 US 12,447,228